Sarepta CFO has 13,272 shares withheld for taxes

Sarepta’s CFO used 13,272 shares to cover taxes on vesting RSUs, leaving 121,792 shares held directly.

Rhea-AI Filing Summary

Sarepta Therapeutics, Inc. (SRPT) reported that its Chief Financial Officer, Ryan Ho-Yan Wong, had 13,272 shares of common stock withheld on September 4, 2026 to pay tax liabilities tied to the vesting of restricted stock units granted on September 3, 2025. After this withholding, he directly holds 121,792 shares of Sarepta common stock. No transactions were made under a Rule 10b5-1 trading plan.

Insider Trade Summary

Tax Withholding: 13,272 shares

Tax Withholding 1 txn

Insider Wong Ryan Ho-Yan

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	13,272	$22.22	$295K

Holdings After Transaction: Common Stock — 121,792 shares (Direct)

Footnotes (1)

1. F1. Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025.

Key Figures

Shares withheld for taxes: 13,272 shares Per-share value for withholding: $22.22 per share Shares held after transaction: 121,792 shares +1 more

4 metrics

Shares withheld for taxes 13,272 shares Common stock used to satisfy tax withholding obligations on September 4, 2026

Per-share value for withholding $22.22 per share Reported value for the 13,272 withheld shares on September 4, 2026

Shares held after transaction 121,792 shares Direct holdings of Sarepta common stock by the CFO after September 4, 2026 transaction

Exercise price or tax-liability shares 13,272 shares Total shares reported as delivered or withheld for tax liability in this Form 4

Key Terms

restricted stock units, tax withholding obligations, withheld by the Company

3 terms

restricted stock units financial

"related to vesting of restricted stock units granted on September 3, 2025"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"Shares were withheld by the Company to satisfy tax withholding obligations"

withheld by the Company financial

"Shares were withheld by the Company to satisfy tax withholding obligations"

FAQ

What insider transaction did SRPT’s CFO report on September 4, 2026?

Sarepta’s CFO, Ryan Ho-Yan Wong, reported that 13,272 shares of common stock were withheld on September 4, 2026 to satisfy tax withholding obligations related to vesting restricted stock units granted on September 3, 2025.

How many SRPT shares does the CFO hold after this Form 4 transaction?

After the September 4, 2026 tax-withholding transaction, Sarepta’s CFO directly holds 121,792 shares of Sarepta Therapeutics common stock, as reported in the Form 4 filing.

Was the SRPT CFO’s September 4, 2026 transaction a market sale or purchase?

No. The Form 4 states the transaction was a payment of tax liability by delivering or withholding securities. Shares were withheld by Sarepta to cover taxes on vesting restricted stock units, not sold or purchased in the open market.

What price per share is associated with the SRPT CFO’s tax-withholding transaction?

The Form 4 reports a value of $22.22 per share for the 13,272 shares withheld on September 4, 2026 in connection with payment of tax liabilities on vesting restricted stock units.

Was the SRPT CFO’s September 4, 2026 transaction under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is unchecked, and there is no footnote indicating that the September 4, 2026 tax-withholding transaction was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 08:05 PM Accepted by SEC EDGAR 09/08/2026 - 08:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wong Ryan Ho-Yan

(Last) (First) (Middle)

215 FIRST STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sarepta Therapeutics, Inc. [ SRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2026		F(1)		13,272	D	$22.22	121,792	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025.

	/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ryan Ho-Yan Wong	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)